# OnCo record raltitrexed (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/raltitrexed/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "raltitrexed" ;
  schema:name "Raltitrexed"@en ;
  schema:alternateName "ZD1694"@en, "Tomudex" ;
  schema:description "Raltitrexed is a three-weekly intravenous antifolate used in Europe, Canada and Australia for advanced bowel cancer, and with cisplatin for mesothelioma, in patients who cannot take fluorouracil."@en ;
  schema:url <https://onco.cc/drugs/raltitrexed/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Raltitrexed> ;
  schema:citation <https://en.wikipedia.org/wiki/Raltitrexed>, <https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL225071> ;
  onco:status "established" ;
  onco:tag "gap-fill", "chembl-universe" ;
  onco:modality "Antifolate thymidylate synthase inhibitor, intravenous every three weeks" ;
  onco:cancers <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/mesothelioma/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:targets <https://onco.cc/targets/tyms/> ;
  onco:drugs <https://onco.cc/drugs/fluorouracil/>, <https://onco.cc/drugs/pemetrexed/> ;
  onco:companies <https://onco.cc/companies/astrazeneca/> ;
  onco:trials <https://onco.cc/trials/nct00002893/>, <https://onco.cc/trials/nct05701436/>, <https://onco.cc/trials/nct05766605/> .